Get started
Author

Frédérique Végran

Observed names: F Végran, F. Vegran, F. Végran, F.V. Vegran, Frederique Vegran, Frederique Végran, Frédérique Végran, Frédérique VEGRAN, Frédérique Vegran, Végran Frédérique, Végran, Frédérique
Institutions: Inserm, Université de Bourgogne, Centre Georges François Leclerc, Université Bourgogne Franche-Comté, Institut Agro Dijon, Centre de recherche Translationnelle en Médecine moléculaire
Observed institutions: University of Geneva, Centre National de la Recherche Scientifique, University of Namur, Inserm, University of Cape Town, Université de Bourgogne, Centre Georges François Leclerc, University Hospital of Geneva, Immunologie et Neurogénétique Expérimentales et Moléculaires, CHU Dijon Bourgogne, Université Bourgogne Franche-Comté, Genomic and Immunotherapy Medical Institute, Institut Agro Dijon, Centre de recherche Translationnelle en Médecine moléculaire, Institut de Chimie Moléculaire de l'Université de Bourgogne, UCLouvain, University of Lausanne
ORCID: 0000-0002-4377-1441
Observed ORCID: 0000-0002-4377-1441
OpenAlex ID: A5046253661
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
2008 · Pierre Sonveaux, Frédérique Végran, et al. · Journal of Clinical Investigation · 1,686
Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis
2011 · Frédérique Végran, Romain Boidot, et al. · Cancer Research · 841
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
2012 · Mélanie Bruchard, Grégoire Mignot, et al. · Nature Medicine · 797
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
2012 · Pierre Sonveaux, Tamara Copetti, et al. · PLoS ONE · 553
PDF
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation
2015 · Mélanie Bruchard, Cédric Rebé, et al. · Nature Immunology · 407
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
2012 · Fanny Chalmin, Grégoire Mignot, et al. · Immunity · 365
PDF
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
2016 · Emeric Limagne, Romain Euvrard, et al. · Cancer Research · 280
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
2014 · Frédérique Végran, Hélène Berger, et al. · Nature Immunology · 250
Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors
2011 · Romain Boidot, Frédérique Végran, et al. · Cancer Research · 238
STAT3 activation
2013 · Cédric Rébé, Frédérique Végran, et al. · JAK-STAT · 222
PDF
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
2018 · Magalie Dosset, Thaiz Rivera Vargas, et al. · OncoImmunology · 219
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
2022 · Mannon GEINDREAU, Mélanie BRUCHARD, et al. · Cancers · 151
PDF
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells
2014 · V Derangère, A Chevriaux, et al. · Cell Death and Differentiation · 150
PDF
Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
2013 · Hélène Bugaut, Mélanie Bruchard, et al. · PLoS ONE · 127
PDF
Follicular helper-T cells restore CD8 + -dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
2021 · Julie Niogret, Hélène Berger, et al. · Journal for ImmunoTherapy of Cancer · 119
PDF
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
2022 · Mélanie Bruchard, Mannon Geindreau, et al. · Nature Immunology · 101
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
2012 · Alice Hervieu, Cédric Rébé, et al. · Journal of Investigative Dermatology · 93
TH9 cells in anti-tumor immunity
2016 · Thaiz Rivera Vargas, Etienne Humblin, et al. · Seminars in Immunopathology · 92
PDF
Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer
2015 · Frédérique Végran, Lionel Apetoh, et al. · Cancer Research · 91
PDF
Cleaved Caspase-3 Transcriptionally Regulates Angiogenesis-Promoting Chemotherapy Resistance
2019 · Antoine Bernard, Sandy Chevrier, et al. · Cancer Research · 85
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T H 1 and T H 9 cells
2022 · Isis Benoit-Lizon, Elise Jacquin, et al. · Journal for ImmunoTherapy of Cancer · 84
PDF
Overexpression of Caspase-3s Splice Variant in Locally Advanced Breast Carcinoma Is Associated with Poor Response to Neoadjuvant Chemotherapy
2006 · Frédérique Végran, Romain Boidot, et al. · Clinical Cancer Research · 80
Transcriptional regulation of the survivin gene
2013 · Romain Boidot, Frédérique Végran, et al. · Molecular Biology Reports · 79
IRF8-dependent molecular complexes control the Th9 transcriptional program
2017 · Etienne Humblin, Marion Thibaudin, et al. · Nature Communications · 73
PDF
Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
2011 · L. Apetoh, F. Vegran, et al. · Current Molecular Medicine · 71
Works count: 138
Citation count: 8,293
H-index: 36
I10-index: 57
Year
Topic
Type